Name,Fullname,Description,Type,Unit
sample_id,Sample ID,Unique string identifying each subject,string,NA
patient_cohort,Patient's Cohort,"Cohort 1,  previously used samples; Cohort 2, newly added samples",string,NA
sample_origin,Sample Origin,"BPTB: Barts Pancreas Tissue Bank; ESP: Spanish National Cancer Research Centre; LIV: Liverpool University;UCL: University College",string,NA
age,Age,Age in years,int,years
sex,Sex,"M = male, F = female",char,NA
diagnosis,"Diagnosis (1=Control, 2=Benign, 3=PDAC)","1 = control, 2 = benign hepatobiliary disease; 3 = Pancreatic ductal adenocarcinoma, i.e. pancreatic cancer",int,NA
stage,Stage,"For those with pancratic cancer, what stage was it? One of IA, IB, IIA, IIIB, III, IV",string,NA
benign_sample_diagnosis,Benign Samples Diagnosis,"For those with a benign, non-cancerous diagnosis, what was the diagnosis?",string,NA
plasma_CA19_9,Plasma CA19-9 U/ml,Blood plasma levels of CA 19â€“9 monoclonal antibody that is often elevated in patients with pancreatic cancer.,float,plasma units/milliliter
creatinine,Creatinine mg/ml,Urinary biomarker of kidney function,float, mg/ml
LYVE1,LYVE1 ng/ml,"Urinary levels of Lymphatic vessel endothelial hyaluronan receptor 1, a protein that may play a role in tumor metastasis",float,ng/ml
REG1B,REG1B ng/ml,Urinary levels of a protein that may be associated with pancreas regeneration.,float,ng/ml
TFF1,TFF1 ng/ml,"Urinary levels of Trefoil Factor 1, which may be related to regeneration and repair of the urinary tract",float,ng/ml
REG1A,REG1A ng/ml,Urinary levels of a protein that may be associated with pancreas regeneration.,float,ng/ml
